IRAP Inhibitors: M1-Aminopeptidase Family Inspiration

Research output: Contribution to journalReview ArticleResearchpeer-review

4 Citations (Scopus)


The insulin regulated aminopeptidase (IRAP) has been proposed as an important therapeutic target for indications including Alzheimer’s disease and immune disorders. To date, a number of IRAP inhibitor designs have been investigated but the total number of molecules investigated remains quite small. As a member the M1 aminopeptidase family, IRAP shares numerous structural features with the other M1 aminopeptidases. The study of those enzymes and the development of inhibitors provide key learnings and new approaches and are potential sources of inspiration for future IRAP inhibitors.

Original languageEnglish
Article number585930
Number of pages8
JournalFrontiers in Pharmacology
Publication statusPublished - 25 Sep 2020


  • aminopeptidase
  • enzyme inhibitor design
  • insulin regulated aminopeptidase
  • peptidomimetic
  • small molecule inhibitor
  • transition state analog

Cite this